Cresco Labs (CSE: CL) (OTCQX: CRLBF) - Investor Dashboard

➔ Cresco Labs
CSE Ticker: CL
Market Focus: United States
Classification: Vertically Integrated
Country: United States
Employees: ~3500 as of Jan 2022
Established: 2013
CEO: Charles Bachtell


Fiscal Year-End: December
Auditor: Marcum LLP
Exchanges: CSE, OTCQX
Sector:  Healthcare
States: 10
Headquarters: Chicago, IL

Financials (09/30/22)

Cash on hand: $130.0 million
Fixed Investment: $377.9 million
Shareholders’ Equity: $771.5 million
Revenues – Last Quarter: $210.5 million
Gross Margin : 47.1%
EPS : -0.03

Capital Structure (11/15/22)

Last Financing: 9.9 million shares at C$16.00
Shares: 407.1 million
Warrants: 2.1 million
Options: 23.5 million
Diluted Shares: 437.4 million

Company Brief

Cresco Labs (CSE: CL) (OTCQX: CRLBF), based in Chicago, is a leading U.S. cannabis company with experienced management, access to capital and a demonstrated growth strategy. As a differentiated grower, processor and retailer of premium cannabis with operations in 10 states, the company focuses on entering markets with outsized demand potential, significant supply constraints and high barriers to entry.

Its unparalleled speed-to-market gives Cresco Labs a distinct competitive advantage as it replicates its model to expand its national footprint. Cresco Labs’s proven ability to execute is complemented by a well-defined brand strategy that is tailored to all major consumer segments: everyday cannabis, medicinally focused, connoisseur grade, and chef-inspired edibles by James Beard Award-winning pastry chef Mindy Segal. The company’s growth strategy is focused on brands and distribution.

Cresco Labs and Columbia Care Merger


Cresco Labs has expanded significantly through acquisitions. It grew its footprint in Florida market with the acquisition of Bluma Wellness, and it is creating a leading position in Massachusetts with the closed acquisition of vertically integrated operator Cultivate.

Columbia Care Acquisition

Cresco Labs has entered into a definitive agreement to acquire Columbia Care, a deal that is expected to close in the fourth quarter of 2022. The combination of the companies will give Cresco Labs more than 130 retail stores across 18 markets. Click here to learn more about the transaction.


  • One of the largest, vertically integrated multi-state operators
  • Brands to address variant consumer groups: Remedi, Cresco, Mindy’s, Wonder Wellness Co., High Supply, Good News, and dispensary brand Sunnyside
  • Strong medical advisory board and R&D partnerships with leading institutions and universities
  • 53 operating dispensaries and 19 cultivation and production facilities
  • More than 2,600 SKUs sold through the wholesale portfolio
  • Operations in Illinois, Pennsylvania, Ohio, Arizona, Maryland, California, Massachusetts, New York, Michigan and Florida
  • Branded products sold through company-owned dispensaries and through wholesale; products sold in more than 1,100 dispensaries across the country
  • One of 10 vertically integrated license holders in New York; operating four store
  • 19 stores in Florida

Growth Strategy

  • Leveraging success in the Illinois, Pennsylvania and California markets to expand into states like Florida, Michigan, New York and Massachusetts
  • Acquisitions helping the company serve the growing adult-use market in Massachusetts
  • Create licensing and/or distribution partnerships to expand Mindy Segal edible products
  • Developing a variety of products based on traditional pharmaceutical delivery systems: pills, tinctures, topical salves, transdermal patches and edible forms with a variety of cannabinoid profiles
  • Marketing strategy driven by awareness and education, in-store experience, and outreach
  • Actively pursuing the acquisition of licenses and existing cannabis operations


  • Leading market share in three $1B+ markets
  • Holds two of seven licenses available in Chicago’s Central District and one of six available licenses in the Southeast District
  • 630,000 square feet of potential canopy space and 10 stores in Illinois
  • 88,000 square feet of cultivation in Pennsylvania and 10 stores; five additional retail licenses
  • Holds the maximum number of retail licenses (five) in Ohio following the acquisition of four Verdant Creations’ dispensaries
  • Social Equity and Education Development (SEED) initiative aims to make the cannabis space more inclusive

Building Distinct Brands That Scale

Institutional Analyst Coverage

Kenric Tyghe
ATB Capital Markets

Jesse Pytlak
Cormark Securities Inc.

Glenn Mattson
Ladenburg Thalmann

Russell Stanley
Beacon Securities

Vivien Azer
Cowen, Inc.

Matthew McGinley

Scott Fortune
ROTH Capital Partners

Derek Dley
Canaccord Genuity

Matthew Pallotta
Echelon Partners

Jason Zandberg
PI Financial

Andrew Partheniou

Pablo Zuanic
Cantor Fitzgerald

Graeme Kreindler
Eight Capital

Michael S. Lavery
Piper Jaffray

Curated Stories & News

Visit Cresco Labs, Inc.

New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. Cresco Labs, Inc. is a client of NCV Media, LLC. Read our full disclaimer.